Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 2
2011 3
2012 4
2013 5
2014 5
2015 7
2016 7
2017 5
2018 2
2019 2
2020 6
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Results by year
Filters applied: . Clear all
Page 1
Targeted therapies in pulmonary arterial hypertension.
Montani D, Chaumais MC, Guignabert C, Günther S, Girerd B, Jaïs X, Algalarrondo V, Price LC, Savale L, Sitbon O, Simonneau G, Humbert M. Montani D, et al. Among authors: chaumais mc. Pharmacol Ther. 2014 Feb;141(2):172-91. doi: 10.1016/j.pharmthera.2013.10.002. Epub 2013 Oct 14. Pharmacol Ther. 2014. PMID: 24134901 Free article. Review.
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.
Guignabert C, Phan C, Seferian A, Huertas A, Tu L, Thuillet R, Sattler C, Le Hiress M, Tamura Y, Jutant EM, Chaumais MC, Bouchet S, Manéglier B, Molimard M, Rousselot P, Sitbon O, Simonneau G, Montani D, Humbert M. Guignabert C, et al. Among authors: chaumais mc. J Clin Invest. 2016 Sep 1;126(9):3207-18. doi: 10.1172/JCI86249. Epub 2016 Aug 2. J Clin Invest. 2016. PMID: 27482885 Free PMC article. Clinical Trial.
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors.
Weatherald J, Bondeelle L, Chaumais MC, Guignabert C, Savale L, Jaïs X, Sitbon O, Rousselot P, Humbert M, Bergeron A, Montani D. Weatherald J, et al. Among authors: chaumais mc. Eur Respir J. 2020 Oct 29;56(4):2000279. doi: 10.1183/13993003.00279-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32527740 Review.
Interferon-induced pulmonary hypertension: an update.
Savale L, Chaumais MC, O'Connell C, Humbert M, Sitbon O. Savale L, et al. Among authors: chaumais mc. Curr Opin Pulm Med. 2016 Sep;22(5):415-20. doi: 10.1097/MCP.0000000000000307. Curr Opin Pulm Med. 2016. PMID: 27387101 Review.
Sex and gender in pulmonary arterial hypertension.
Cheron C, McBride SA, Antigny F, Girerd B, Chouchana M, Chaumais MC, Jaïs X, Bertoletti L, Sitbon O, Weatherald J, Humbert M, Montani D. Cheron C, et al. Among authors: chaumais mc. Eur Respir Rev. 2021 Nov 8;30(162):200330. doi: 10.1183/16000617.0330-2020. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34750113 Free article. Review.
Drugs induced pulmonary arterial hypertension.
Seferian A, Chaumais MC, Savale L, Günther S, Tubert-Bitter P, Humbert M, Montani D. Seferian A, et al. Among authors: chaumais mc. Presse Med. 2013 Sep;42(9 Pt 2):e303-10. doi: 10.1016/j.lpm.2013.07.005. Epub 2013 Aug 22. Presse Med. 2013. PMID: 23972547 Review.
Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
Ranchoux B, Günther S, Quarck R, Chaumais MC, Dorfmüller P, Antigny F, Dumas SJ, Raymond N, Lau E, Savale L, Jaïs X, Sitbon O, Simonneau G, Stenmark K, Cohen-Kaminsky S, Humbert M, Montani D, Perros F. Ranchoux B, et al. Among authors: chaumais mc. Am J Pathol. 2015 Feb;185(2):356-71. doi: 10.1016/j.ajpath.2014.10.021. Epub 2014 Dec 11. Am J Pathol. 2015. PMID: 25497573 Free article. Review.
New pharmacotherapy options for pulmonary arterial hypertension.
Perrin S, Chaumais MC, O'Connell C, Amar D, Savale L, Jaïs X, Montani D, Humbert M, Simonneau G, Sitbon O. Perrin S, et al. Among authors: chaumais mc. Expert Opin Pharmacother. 2015;16(14):2113-31. doi: 10.1517/14656566.2015.1074177. Epub 2015 Aug 12. Expert Opin Pharmacother. 2015. PMID: 26290279 Review.
53 results